vs
Side-by-side financial comparison of Celanese Corp (CE) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
Celanese Corp is the larger business by last-quarter revenue ($2.3B vs $1.3B, roughly 1.8× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 7.3% vs 2.1%, a 5.2% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs -2.2%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $3.0M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs -6.1%).
Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the world's leading producer of acetic acid, producing about 1.95 million tonnes per year, representing approximately 20% of global production. Celanese is also the world's largest producer of vinyl acetate monomer (VAM).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
CE vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.3B | $1.3B |
| Net Profit | $48.0M | $97.3M |
| Gross Margin | 20.0% | 14.9% |
| Operating Margin | — | 83.4% |
| Net Margin | 2.1% | 7.3% |
| Revenue YoY | -2.2% | 4.8% |
| Net Profit YoY | 340.0% | -42.0% |
| EPS (diluted) | $0.41 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.3B | $1.3B | ||
| Q4 25 | $2.2B | $339.0M | ||
| Q3 25 | $2.4B | $327.3M | ||
| Q2 25 | $2.5B | $321.4M | ||
| Q1 25 | $2.4B | $330.6M | ||
| Q4 24 | $2.4B | $348.5M | ||
| Q3 24 | $2.6B | $345.5M | ||
| Q2 24 | $2.7B | $336.2M |
| Q1 26 | $48.0M | $97.3M | ||
| Q4 25 | $14.0M | $44.7M | ||
| Q3 25 | $-1.4B | $38.7M | ||
| Q2 25 | $199.0M | $34.0M | ||
| Q1 25 | $-21.0M | $58.0M | ||
| Q4 24 | $-1.9B | $37.5M | ||
| Q3 24 | $116.0M | $33.8M | ||
| Q2 24 | $155.0M | $38.4M |
| Q1 26 | 20.0% | 14.9% | ||
| Q4 25 | 19.1% | 59.7% | ||
| Q3 25 | 21.5% | 59.5% | ||
| Q2 25 | 21.1% | 59.8% | ||
| Q1 25 | 19.9% | 58.4% | ||
| Q4 24 | 22.7% | 55.5% | ||
| Q3 24 | 23.5% | 54.2% | ||
| Q2 24 | 24.2% | 52.0% |
| Q1 26 | — | 83.4% | ||
| Q4 25 | 4.0% | 19.9% | ||
| Q3 25 | -52.7% | 17.9% | ||
| Q2 25 | 9.2% | 16.8% | ||
| Q1 25 | 7.0% | 21.6% | ||
| Q4 24 | -59.3% | 16.9% | ||
| Q3 24 | 9.4% | 15.0% | ||
| Q2 24 | 9.4% | 11.8% |
| Q1 26 | 2.1% | 7.3% | ||
| Q4 25 | 0.6% | 13.2% | ||
| Q3 25 | -56.1% | 11.8% | ||
| Q2 25 | 7.9% | 10.6% | ||
| Q1 25 | -0.9% | 17.5% | ||
| Q4 24 | -80.8% | 10.8% | ||
| Q3 24 | 4.4% | 9.8% | ||
| Q2 24 | 5.8% | 11.4% |
| Q1 26 | $0.41 | — | ||
| Q4 25 | $0.13 | $0.95 | ||
| Q3 25 | $-12.39 | $0.81 | ||
| Q2 25 | $1.81 | $0.70 | ||
| Q1 25 | $-0.19 | $1.17 | ||
| Q4 24 | $-17.50 | $0.74 | ||
| Q3 24 | $1.06 | $0.66 | ||
| Q2 24 | $1.41 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8M | $245.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $4.5M | $796.3M |
| Total Assets | $21.7M | $2.4B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8M | $245.4M | ||
| Q4 25 | — | $363.4M | ||
| Q3 25 | — | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | — | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | — | $299.3M | ||
| Q2 24 | — | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $11.4B | $1.2B | ||
| Q3 25 | $11.7B | $1.2B | ||
| Q2 25 | $12.7B | $1.2B | ||
| Q1 25 | $12.4B | $1.2B | ||
| Q4 24 | $11.1B | — | ||
| Q3 24 | $11.3B | — | ||
| Q2 24 | $11.1B | — |
| Q1 26 | $4.5M | $796.3M | ||
| Q4 25 | $4.0B | $911.5M | ||
| Q3 25 | $4.0B | $849.2M | ||
| Q2 25 | $5.3B | $882.3M | ||
| Q1 25 | $5.2B | $820.8M | ||
| Q4 24 | $5.2B | $906.9M | ||
| Q3 24 | $7.3B | $878.9M | ||
| Q2 24 | $7.2B | $905.4M |
| Q1 26 | $21.7M | $2.4B | ||
| Q4 25 | $21.7B | $2.5B | ||
| Q3 25 | $22.2B | $2.4B | ||
| Q2 25 | $23.7B | $2.5B | ||
| Q1 25 | $23.2B | $2.5B | ||
| Q4 24 | $22.9B | $2.5B | ||
| Q3 24 | $25.9B | $2.5B | ||
| Q2 24 | $25.8B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | 2.81× | 1.34× | ||
| Q3 25 | 2.95× | 1.44× | ||
| Q2 25 | 2.41× | 1.39× | ||
| Q1 25 | 2.39× | 1.49× | ||
| Q4 24 | 2.14× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.2M |
| Free Cash FlowOCF − Capex | $3.0M | $209.9M |
| FCF MarginFCF / Revenue | 0.1% | 15.7% |
| Capex IntensityCapex / Revenue | 2.8% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $871.0M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $252.0M | $93.6M | ||
| Q3 25 | $447.0M | $111.3M | ||
| Q2 25 | $410.0M | $17.4M | ||
| Q1 25 | $37.0M | $116.6M | ||
| Q4 24 | $494.0M | $43.8M | ||
| Q3 24 | $79.0M | $48.8M | ||
| Q2 24 | $292.0M | $-27.4M |
| Q1 26 | $3.0M | $209.9M | ||
| Q4 25 | $168.0M | $87.2M | ||
| Q3 25 | $383.0M | $106.3M | ||
| Q2 25 | $317.0M | $13.6M | ||
| Q1 25 | $-65.0M | $100.9M | ||
| Q4 24 | $389.0M | $35.2M | ||
| Q3 24 | $-9.0M | $39.4M | ||
| Q2 24 | $187.0M | $-33.1M |
| Q1 26 | 0.1% | 15.7% | ||
| Q4 25 | 7.6% | 25.7% | ||
| Q3 25 | 15.8% | 32.5% | ||
| Q2 25 | 12.5% | 4.2% | ||
| Q1 25 | -2.7% | 30.5% | ||
| Q4 24 | 16.4% | 10.1% | ||
| Q3 24 | -0.3% | 11.4% | ||
| Q2 24 | 7.1% | -9.8% |
| Q1 26 | 2.8% | 2.5% | ||
| Q4 25 | 3.8% | 1.9% | ||
| Q3 25 | 2.6% | 1.5% | ||
| Q2 25 | 3.7% | 1.2% | ||
| Q1 25 | 4.3% | 4.7% | ||
| Q4 24 | 4.4% | 2.5% | ||
| Q3 24 | 3.3% | 2.7% | ||
| Q2 24 | 4.0% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 18.00× | 2.09× | ||
| Q3 25 | — | 2.88× | ||
| Q2 25 | 2.06× | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | 0.68× | 1.44× | ||
| Q2 24 | 1.88× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
